Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 8.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| CX | NUVB | |
|---|---|---|
Market Cap | $13.84B | $1.71B |
Volume | 6,589,714 | 5,448,712 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $9.54 |
52-Week Low | $9.12 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.83B | $1.30B |
Dividend Yield | 1.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
